Publications

• Safety and efficacy of valoctocogene roxaparvovec with prophylactic glucocorticoids: 1-year results from the phase 3b, single-arm, open-label GENEr8-3 study.
  J Thromb Haemost Volume: 23 Page(s): 1496 - 1506
  05/01/2025 Authors: Ozelo MC; Mason J; Dunn AL; Villaa PR; Shen M-C; Agarwal S; Imtiaz U; Liu H; Robinson TM
• Bleed treatment with eptacog beta (rFVIIa) results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitors.
  Haemophilia Volume: 31 Page(s): 78 - 86
  01/01/2025 Authors: Dunn A; Dargaud Y; Abajas Y; Carcao M; Castaman G; Giermasz A; Hermans C; Jimnez-Yuste V; Lewandowska M; Mahlangu J
• Improving 1-Deamino-8-D-Arginine Vasopressin (DDAVP) Challenges in Pediatric/Young Adult Patients With Bleeding Disorders: A Quality Improvement Study.
  J Pediatr Hematol Oncol Nurs Volume: 41 Page(s): 292 - 297
  07/01/2024 Authors: Hallam M; Pruett A; Biega C; Miller H; Davis T; Casto L; Dunn AL; Rodriguez V
• Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A.
  J Thromb Haemost Volume: 22 Page(s): 1880 - 1893
  07/01/2024 Authors: Madan B; Ozelo MC; Raheja P; Symington E; Quon DV; Leavitt AD; Pipe SW; Lowe G; Kenet G; Reding MT
• International Prophylaxis Study Group (IPSG) haemophilia joint MRI scale version 2.0.
  Haemophilia Volume: 30 Page(s): 862 - 864
  05/01/2024 Authors: Lundin B; Bakeer N; Dunn AL; Gibikote S; Keshava SN; Ljung RCR; Papakonstantinou O; Pergantou H; Strike K; Drygalski AV
• Increasing optimal coagulation factor dosing in the paediatric emergency department: Update to a quality improvement study.
  Haemophilia Volume: 30 Page(s): 367 - 374
  03/01/2024 Authors: Kendel NE; Abdelghani E; Stanek JR; Mitchell B; Dunn MW; Rodriguez V; Dunn AL
• Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1.
  J Thromb Haemost Volume: 21 Page(s): 3450 - 3462
  12/01/2023 Authors: O'Mahony B; Dunn AL; Leavitt AD; Peyvandi F; Ozelo MC; Mahlangu J; Peerlinck K; Wang J-D; Lowe GC; Tan CW
• A regional anticoagulation program improves safety and outcomes for both children and adults.
  J Thromb Thrombolysis Volume: 56 Page(s): 27 - 36
  07/01/2023 Authors: Rodriguez V; Stanek J; Cua CL; Sankar A; Giver J; Monda K; Canini J; Dunn AL; Kerlin BA
• Mild Hemophilia in a Competitive High School Soccer Player: A Case Report.
  J Athl Train Volume: 58 Page(s): 669 - 672
  07/01/2023 Authors: Omole O; Reed J; Dunn AL; Gleason CN
• Impact of SERPINC1 mutation on thrombotic phenotype in children with congenital antithrombin deficiency-first analysis of the International Society on Thrombosis and Haemostasis pediatric antithrombin deficiency database and biorepository.
  J Thromb Haemost Volume: 21 Page(s): 1248 - 1257
  05/01/2023 Authors: Kumar R; Bakeer N; Dawson J; Al-Mughairy A; Stanek J; Dunn A; Male C; Chan A; Williams S
• Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia.
  Expert Rev Hematol Volume: 16 Page(s): 19 - 37
  03/01/2023 Authors: Tran DQ; Benson CC; Boice JA; Chitlur M; Dunn AL; Escobar MA; Gupta K; Johnsen JM; Jorgenson J; Martin SD
• Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A.
  N Engl J Med Volume: 388 Page(s): 694 - 705
  02/23/2023 Authors: Mahlangu J; Kaczmarek R; von Drygalski A; Shapiro S; Chou S-C; Ozelo MC; Kenet G; Peyvandi F; Wang M; Madan B
• Efficacy and safety evaluation of eptacog beta (coagulation factor VIIa [recombinant]-jncw) for the treatment of hemophilia A and B with inhibitors.
  Expert Rev Hematol Volume: 16 Page(s): 715 - 729
  01/01/2023 Authors: Pipe SW; Dunn AL; Young G
• Moderate-intensity aerobic exercise vs desmopressin in adolescent males with mild hemophilia A: a randomized trial.
  Blood Volume: 140 Page(s): 1156 - 1166
  09/08/2022 Authors: Kumar R; Dunn AL; Schneiderman JE; Gonzales A; Bouskill V; Widener P; Stanek J; Pluthero FG; Waller A; Tarango C
• Achieving access to haemophilia care in low-income and lower-middle-income countries: expanded Humanitarian Aid Program of the World Federation of Hemophilia after 5 years.
  Lancet Haematol Volume: 9 Page(s): e689 - e697
  09/01/2022 Authors: Pierce GF; Adediran M; Diop S; Dunn AL; El Ekiaby M; Kaczmarek R; Konkle BA; Pipe SW; Skinner MW; Valentino LA
• A phase IV, multicentre, open-label study of emicizumab prophylaxis in people with haemophilia A with or without FVIII inhibitors undergoing minor surgical procedures.
  Haemophilia Volume: 28 Page(s): e105 - e108
  07/01/2022 Authors: Escobar M; Dunn A; Quon D; Trzaskoma B; Lee L; Ko RH; Carpenter SL
• Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors.
  Haemophilia Volume: 28 Page(s): 548 - 556
  07/01/2022 Authors: Pipe SW; Hermans C; Chitlur M; Carcao M; Castaman G; Davis JA; Ducore J; Dunn AL; Escobar M; Journeycake J
• First study of extended half-life rFVIIIFc in previously untreated patients with hemophilia A: PUPs A-LONG final results.
  Blood Volume: 139 Page(s): 3699 - 3707
  06/30/2022 Authors: Knigs C; Ozelo MC; Dunn A; Kulkarni R; Nolan B; Brown SA; Schiavulli M; Gunawardena S; Mukhopadhyay S; Jayawardene D
• Andexanet Alfa Versus Prothrombin Complex Concentrates/Blood Products as Apixaban/Rivaroxaban Reversal Agents: A Survey Among Pediatric Hematologists.
  Clin Appl Thromb Hemost Volume: 28 Page(s): 10760296221078842
  01/01/2022 Authors: Rodriguez V; Stanek J; Kerlin BA; Dunn AL
• Enoxaparin Dose Requirements to Achieve Therapeutic Low-molecular-weight Heparin Anti-factor Xa Levels in Infants and Young Children.
  J Pediatr Hematol Oncol Volume: 43 Page(s): e946 - e950
  10/01/2021 Authors: Wysocki EL; Kuhn A; Steinbrenner J; Tyrrell L; Abdel-Rasoul M; Dunn A; Cloyd C
• Fibrinogen Columbus III: A novel c.963del frameshift mutation in the FGG gene resulting in hypofibrinogenemia with a bleeding phenotype.
  Pediatr Blood Cancer Volume: 68 Page(s): e28713
  03/01/2021 Authors: Abdelghani E; Dawson J; Zajo K; Hallam M; Dunn A; Kumar R
• Unfractionated heparin using actual body weight without dose capping in obese pediatric patients-Subgroup analysis from an observational cohort study.
  Pediatr Blood Cancer Volume: 68 Page(s): e28872
  03/01/2021 Authors: Kuhn AK; Saini S; Stanek J; Dunn A; Kumar R
• Outcomes for studies assessing the efficacy of hemostatic therapies in persons with congenital bleeding disorders.
  Haemophilia Volume: 27 Page(s): 211 - 220
  03/01/2021 Authors: Aquino CC; Borg Debono V; Germini F; Pete D; Kempton CL; Young G; Sidonio R; Croteau SE; Dunn AL; Key NS
• Laboratory variability in the diagnosis of type 2 VWD variants.
  J Thromb Haemost Volume: 19 Page(s): 131 - 138
  01/01/2021 Authors: DiGiandomenico S; Christopherson PA; Haberichter SL; Abshire TC; Montgomery RR; Flood VH; Zimmerman Program Investigators
• Long-term follow-up of neonatal intracranial haemorrhage in children with severe haemophilia.
  Br J Haematol Volume: 190 Page(s): e101 - e104
  07/01/2020 Authors: Andersson NG; Wu R; Carcao M; Claeyssens-Donadel S; Kobelt R; Liesner R; Mkipernaa A; Ranta S; Ljung R; ICH study group
• Critical appraisal of the International Prophylaxis Study Group magnetic resonance image scale for evaluating haemophilic arthropathy.
  Haemophilia Volume: 26 Page(s): 565 - 574
  07/01/2020 Authors: Tolend M; Majeed H; Soliman M; Daruge P; Bordalo-Rodrigues M; Dertkigil SSJ; Gibikote S; Keshava SN; Stimec J; Dunn A
• Young adult outcomes of childhood prophylaxis for severe hemophilia A: results of the Joint Outcome Continuation Study.
  Blood Adv Volume: 4 Page(s): 2451 - 2459
  06/09/2020 Authors: Warren BB; Thornhill D; Stein J; Fadell M; Ingram JD; Funk S; Norton KL; Lane HD; Bennett CM; Dunn A
• Development and application of global assays of hyper- and hypofibrinolysis.
  Res Pract Thromb Haemost Volume: 4 Page(s): 46 - 53
  01/01/2020 Authors: Ilich A; Noubouossie DF; Henderson M; Ellsworth P; Betbadal KF; Campello E; Meeks S; Dunn A; Park MS; Pawlinski R
• Fibrinogen Columbus II: A novel c.1075G>T mutation in the FGG gene causing hypodysfibrinogenemia and thrombosis in an adolescent male.
  Pediatr Blood Cancer Volume: 66 Page(s): e27832
  09/01/2019 Authors: Kumar R; Dawson J; Varga E; Canini JT; Monda KL; Dunn AL
• Screening urinalysis demonstrates that haematuria is a frequent finding in persons with haemophilia treated at a paediatric haemophilia treatment centre.
  Haemophilia Volume: 25 Page(s): 782 - 788
  09/01/2019 Authors: Davis KA; Stanek JR; Dunn AL
• Inpatient Health Care Utilization in Children With Hemophilia Before and After the Joint Outcome Study Publication.
  J Pediatr Hematol Oncol Volume: 41 Page(s): e284 - e289
  07/01/2019 Authors: Drayton Jackson M; O'Brien SH; Stanek J; Dunn AL; Kerlin BA
• Optimizing patient flow in a multidisciplinary haemophilia clinic using quality improvement methodology.
  Haemophilia Volume: 25 Page(s): 626 - 632
  07/01/2019 Authors: Drayton Jackson M; Bartman T; McGinniss J; Widener P; Dunn AL
• Anti-Factor Xa-Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort.
  J Pediatr Volume: 209 Page(s): 212 - 219.e1
  06/01/2019 Authors: Saini S; Folta AN; Harsh KL; Stanek JR; Dunn AL; O'Brien SH; Kumar R
• Impact of erythrocytapheresis on natural anticoagulant levels in children with sickle cell disease: A pilot study.
  Pediatr Blood Cancer Volume: 66 Page(s): e27588
  04/01/2019 Authors: Sharma R; Woods GM; Creary S; O'Brien S; Stanek J; Hor K; Gallagher C; Dunn AL; Kumar R
• Increasing optimal coagulation factor dosing in the paediatric emergency department: A quality improvement study.
  Haemophilia Volume: 25 Page(s): 258 - 263
  03/01/2019 Authors: Drayton Jackson M; Dunn MW; Storey MA; Dunn AL
• Factor IX inhibitors: Clinical and laboratory profiles of two patients with severe haemophilia B.
  Haemophilia Volume: 25 Page(s): e126 - e129
  03/01/2019 Authors: Saini S; Croteau SE; Horling FM; Dunn AL
• Management of hydrocephalus in infants with severe hemophilia A: report of 2 cases.
  J Neurosurg Pediatr Volume: 23 Page(s): 159 - 163
  02/01/2019 Authors: Bergin SM; Dunn AL; Smith LGF; Drapeau AI
• A Novel Clinician-Orchestrated Virtual Reality Platform for Distraction During Pediatric Intravenous Procedures in Children With Hemophilia: Randomized Controlled Trial.
  JMIR Serious Games Volume: 7 Page(s): e10902
  01/09/2019 Authors: Dunn A; Patterson J; Biega CF; Grishchenko A; Luna J; Stanek JR; Strouse R
• Immunochemical analysis of the expression of SV2C in mouse, macaque and human brain.
  Brain Res Volume: 1702 Page(s): 85 - 95
  01/01/2019 Authors: Dunn AR; Hoffman CA; Stout KA; Ozawa M; Dhamsania RK; Miller GW
• Emicizumab for hemophilia A with factor VIII inhibitors.
  Expert Rev Hematol Volume: 11 Page(s): 835 - 846
  11/01/2018 Authors: Young G; Callaghan M; Dunn A; Kruse-Jarres R; Pipe S
• NMDA receptor blockade ameliorates abnormalities of spike firing of subthalamic nucleus neurons in a parkinsonian nonhuman primate.
  J Neurosci Res Volume: 96 Page(s): 1324 - 1335
  07/01/2018 Authors: Bhattacharya S; Ma Y; Dunn AR; Bradner JM; Scimemi A; Miller GW; Traynelis SF; Wichmann T
• Venous Thromboembolism in Children with Sickle Cell Disease: A Retrospective Cohort Study.
  J Pediatr Volume: 197 Page(s): 186 - 190.e1
  06/01/2018 Authors: Woods GM; Sharma R; Creary S; O'Brien S; Stanek J; Hor K; Young J; Dunn AL; Kumar R
• Real-world experience with use of Antihemophilic Factor (Recombinant), PEGylated for prophylaxis in severe haemophilia A.
  Haemophilia Volume: 24 Page(s): e84 - e92
  05/01/2018 Authors: Dunn AL; Ahuja SP; Mullins ES
• Utilization of a virtual reality based tool in hemophilia education
  Volume: 24 Page(s): 132 - 133
  05/01/2018 Authors: Dunn A; Meeks S; Patterson J; Luna J; Stanek J; Kruse-Jarres R; Kaur D
• Antepartum Care of Women Who Are Obese During Pregnancy: Systematic Review of the Current Evidence.
  J Midwifery Womens Health Volume: 63 Page(s): 259 - 272
  05/01/2018 Authors: Carlson NS; Leslie SL; Dunn A
• Prevalence and risk factors for venous thromboembolism in children with sickle cell disease: an administrative database study.
  Blood Adv Volume: 2 Page(s): 285 - 291
  02/13/2018 Authors: Kumar R; Stanek J; Creary S; Dunn A; O'Brien SH
• Radionuclide synovectomy/synoviorthesis (RS) in patients with bleeding disorders: A review of patient and procedure demographics and functional outcomes in the ATHNdataset.
  Haemophilia Volume: 23 Page(s): 926 - 933
  11/01/2017 Authors: McGuinn C; Cheng D; Aschman D; Carpenter SL; Sidonio R; Soni A; Tarantino MD; Wheeler AP; Dunn AL; ATHN3 Working Group
• Intracranial haemorrhage in children and adolescents with severe haemophilia A or B - the impact of prophylactic treatment.
  Br J Haematol Volume: 179 Page(s): 298 - 307
  10/01/2017 Authors: Andersson NG; Auerswald G; Barnes C; Carcao M; Dunn AL; Fijnvandraat K; Hoffmann M; Kavakli K; Kenet G; Kobelt R
• Activated Partial Thromboplastin Time versus Anti-Factor Xa Levels for Monitoring Unfractionated Heparin Therapy in Children: An Institutional Experience.
  J Pediatr Hematol Oncol Volume: 39 Page(s): 576 - 577
  10/01/2017 Authors: Woods GM; Stanek J; Harrison S; Texter K; Kerlin BA; Dunn AL; Kumar R
• Limit of detection and threshold for positivity of the Centers for Disease Control and Prevention assay for factor VIII inhibitors.
  J Thromb Haemost Volume: 15 Page(s): 1971 - 1976
  10/01/2017 Authors: Miller CH; Boylan B; Shapiro AD; Lentz SR; Wicklund BM; Hemophilia Inhibitor Research Study Investigators
• Radionuclide synovectomy/synoviorthesis (RS) in persons with bleeding disorders: A review of impact of national guidance on frequency of RS using the ATHNdataset.
  Haemophilia Volume: 23 Page(s): e385 - e388
  07/01/2017 Authors: Sharma R; Dunn A; Aschman D; Cheng D; Wheeler A; Soni A; McGuinn C; Knoll C; Stein DT; Young G
• Thrombin Generation in Patients with Severe Hemophilia A is Variable and May be Predictive of Response to Treatment
  Volume: 64 Page(s): S15 - S15
  06/01/2017 Authors: Sharma R; Dunn A; Jobe S; Meeks S
• Radionuclide synovectomy in patients with bleeding disorders: a review of malignancy and myeloproliferative neoplasms from the ATHNdataset.
  Haemophilia Volume: 23 Page(s): e160 - e162
  03/01/2017 Authors: Lim MY; Cheng D; Aschman D; Dunn A; ATHN3 Working Group
• Choosing outcome assessment tools in haemophilia care and research: a multidisciplinary perspective.
  Haemophilia Volume: 23 Page(s): 11 - 24
  01/01/2017 Authors: Fischer K; Poonnoose P; Dunn AL; Babyn P; Manco-Johnson MJ; David JA; van der Net J; Feldman B; Berger K; Carcao M
• The Maternal Infant Microbiome: Considerations for Labor and Birth.
  MCN Am J Matern Child Nurs Volume: 42 Page(s): 318 - 325
  01/01/2017 Authors: Dunn AB; Jordan S; Baker BJ; Carlson NS
• Vesicular Monoamine Transporter 2 (VMAT2) Level Regulates MPTP Vulnerability and Clearance of Excess Dopamine in Mouse Striatal Terminals.
  Toxicol Sci Volume: 153 Page(s): 79 - 88
  09/01/2016 Authors: Lohr KM; Chen M; Hoffman CA; McDaniel MJ; Stout KA; Dunn AR; Wang M; Bernstein AI; Miller GW
• Thrombin generation does not correlate with disease severity but may be predictive of response to treatment in patients with severe hemophilia A
  JOURNAL OF THROMBOSIS AND HAEMOSTASIS Volume: 14 Page(s): 53 - 53
  05/01/2016 Authors: Sharma R; Dunn A; Jobe S; Meeks S
• Changing Paradigm of Hemophilia Management: Extended Half-Life Factor Concentrates and Gene Therapy.
  Semin Thromb Hemost Volume: 42 Page(s): 18 - 29
  02/01/2016 Authors: Kumar R; Dunn A; Carcao M
• An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo.
  Nano Lett Volume: 15 Page(s): 8099 - 8107
  12/09/2015 Authors: Li B; Luo X; Deng B; Wang J; McComb DW; Shi Y; Gaensler KML; Tan X; Dunn AL; Kerlin BA
• Characteristics of hemophilia patients with factor VIII inhibitors detected by prospective screening.
  Am J Hematol Volume: 90 Page(s): 871 - 876
  10/01/2015 Authors: Miller CH; Rice AS; Boylan B; Payne AB; Kelly FM; Escobar MA; Gill J; Leissinger C; Soucie JM; Hemophilia Inhibitor Research Study Investigators
• Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations.
  J Thromb Haemost Volume: 13 Page(s): 1036 - 1042
  06/01/2015 Authors: Boylan B; Rice AS; De Staercke C; Eyster ME; Yaish HM; Knoll CM; Bean CJ; Miller CH; Hemophilia Inhibitor Research Study Investigators
• Crucial role for the VWF A1 domain in binding to type IV collagen.
  Blood Volume: 125 Page(s): 2297 - 2304
  04/02/2015 Authors: Flood VH; Schlauderaff AC; Haberichter SL; Slobodianuk TL; Jacobi PM; Bellissimo DB; Christopherson PA; Friedman KD; Gill JC; Hoffmann RG
• The long and short of it: using the new factor products.
  Hematology Am Soc Hematol Educ Program Volume: 2015 Page(s): 26 - 32
  01/01/2015 Authors: Dunn A
• Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassay.
  J Thromb Haemost Volume: 13 Page(s): 47 - 53
  01/01/2015 Authors: Boylan B; Rice AS; Dunn AL; Tarantino MD; Brettler DB; Barrett JC; Miller CH; Hemophilia Inhibitor Research Study Investigators; Hemophilia Inhibitor Research Study Investigators
• No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation.
  Blood Volume: 121 Page(s): 3742 - 3744
  05/02/2013 Authors: Flood VH; Friedman KD; Gill JC; Haberichter SL; Christopherson PA; Branchford BR; Hoffmann RG; Abshire TC; Dunn AL; Di Paola JA
• Late immune tolerance induction in haemophilia A patients.
  Haemophilia Volume: 19 Page(s): 445 - 448
  05/01/2013 Authors: Meeks SL; Chapman RL; Kempton C; Dunn AL
• A case of pigmented villonodular synovitis in conjunction with a platelet release defect in a paediatric patient.
  Haemophilia Volume: 19 Page(s): e89 - e90
  03/01/2013 Authors: Balakrishnan V; Dunn AL
• An MRI scale for assessment of haemophilic arthropathy from the International Prophylaxis Study Group.
  Haemophilia Volume: 18 Page(s): 962 - 970
  11/01/2012 Authors: Lundin B; Manco-Johnson ML; Ignas DM; Moineddin R; Blanchette VS; Dunn AL; Gibikote SV; Keshava SN; Ljung R; Manco-Johnson MJ
• Evaluation of a novel flow chamber system to assess clot formation in factor VIII-deficient mouse and anti-factor IXa-treated human blood.
  Haemophilia Volume: 18 Page(s): 926 - 932
  11/01/2012 Authors: Ogawa S; Szlam F; Dunn AL; Bolliger D; Ohnishi T; Hosokawa K; Tanaka KA
• Medical radiation exposure in children with bleeding disorders: an institutional experience.
  Haemophilia Volume: 18 Page(s): 888 - 891
  11/01/2012 Authors: Crawford CC; Meeks SL; Dunn AL
• Prevalence of malignancies among U.S. male patients with haemophilia: a review of the Haemophilia Surveillance System.
  Haemophilia Volume: 18 Page(s): 532 - 539
  07/01/2012 Authors: Dunn AL; Austin H; Soucie JM
• Pathophysiology, diagnosis and prevention of arthropathy in patients with haemophilia.
  Haemophilia Volume: 17 Page(s): 571 - 578
  07/01/2011 Authors: Dunn AL
• Adenotonsillectomy in patients with desmopressin responsive mild bleeding disorders: a review of the literature.
  Haemophilia Volume: 16 Page(s): 711 - 716
  09/01/2010 Authors: Dunn AL; Cox Gill J
• Malignancy in patients with haemophilia: a review of the literature.
  Haemophilia Volume: 16 Page(s): 427 - 436
  05/01/2010 Authors: Dunn AL
• Bleeding symptoms and laboratory correlation in patients with severe von Willebrand disease.
  Haemophilia Volume: 15 Page(s): 918 - 925
  07/01/2009 Authors: Metjian AD; Wang C; Sood SL; Cuker A; Peterson SM; Soucie JM; Konkle BA; HTCN Study Investigators
• Sustained engraftment and resolution of bleeding phenotype after unrelated cord blood hematopoietic stem cell transplantation for severe glanzmann thrombasthenia.
  J Pediatr Hematol Oncol Volume: 31 Page(s): 437 - 439
  06/01/2009 Authors: Miller W; Dunn A; Chiang K-Y
• Necrotizing enterocolitis as a result of postcircumcision bleeding in a neonate with haemophilia A.
  Haemophilia Volume: 14 Page(s): 1115 - 1116
  09/01/2008 Authors: Dunn AL
• Recombinant tissue plasminogen activator may reduce frequency of central venous access device infection in hemophilia patients undergoing immune tolerance therapy.
  Pediatr Blood Cancer Volume: 50 Page(s): 627 - 629
  03/01/2008 Authors: Dunn AL; Abshire TC
• Reliability and construct validity of the compatible MRI scoring system for evaluation of elbows in haemophilic children.
  Haemophilia Volume: 14 Page(s): 303 - 314
  03/01/2008 Authors: Doria AS; Lundin B; Miller S; Kilcoyne R; Dunn A; Thomas S; Rivard G; Moineddin R; Babyn PS; Expert Imaging Working Group of The International Prophylaxis Study Group
• Prevention and treatment of musculoskeletal disease in the haemophilia population: role of prophylaxis and synovectomy.
  Haemophilia Volume: 12 Suppl 3 Page(s): 159 - 168
  07/01/2006 Authors: Van den Berg HM; Dunn A; Fischer K; Blanchette VS
• Current issues in prophylactic therapy for persons with hemophilia.
  Acta Haematol Volume: 115 Page(s): 162 - 171
  01/01/2006 Authors: Dunn AL; Abshire TC
• Management and prevention of recurrent hemarthrosis in patients with hemophilia.
  Curr Opin Hematol Volume: 12 Page(s): 390 - 394
  09/01/2005 Authors: Dunn AL
• Leukemia and P32 radionuclide synovectomy for hemophilic arthropathy.
  J Thromb Haemost Volume: 3 Page(s): 1541 - 1542
  07/01/2005 Authors: Dunn AL; Manco-Johnson M; Busch MT; Balark KL; Abshire TC
• Recent advances in the management of the child who has hemophilia.
  Hematol Oncol Clin North Am Volume: 18 Page(s): 1249 - viii
  12/01/2004 Authors: Dunn AL; Abshire TC
• Arthroscopic synovectomy for hemophilic joint disease in a pediatric population.
  J Pediatr Orthop Volume: 24 Page(s): 414 - 426
  01/01/2004 Authors: Dunn AL; Busch MT; Wyly JB; Sullivan KM; Abshire TC
• Radionuclide synovectomy for hemophilic arthropathy: a comprehensive review of safety and efficacy and recommendation for a standardized treatment protocol.
  Thromb Haemost Volume: 87 Page(s): 383 - 393
  03/01/2002 Authors: Dunn AL; Busch MT; Wyly JB; Abshire TC
• Adverse events during use of intranasal desmopressin acetate for haemophilia A and von Willebrand disease: a case report and review of 40 patients.
  Haemophilia Volume: 6 Page(s): 11 - 14
  01/01/2000 Authors: Dunn AL; Powers JR; Ribeiro MJ; Rickles FR; Abshire TC